OptimizeRx Corporation (OPRX)
| Market Cap | 815.62M |
| Revenue (ttm) | 43.31M |
| Net Income (ttm) | -2.21M |
| Shares Out | 16.81M |
| EPS (ttm) | -0.15 |
| PE Ratio | n/a |
| Forward PE | 112.36 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 22 |
| Last Price | $48.53 |
| Previous Close | $48.27 |
| Change ($) | 0.26 |
| Change (%) | 0.54% |
| Day's Open | 48.46 |
| Day's Range | 48.13 - 50.75 |
| Day's Volume | 137,972 |
| 52-Week Range | 8.66 - 63.98 |
Ranked #277, highlighting the growth potential and convergence between technology and healthcare Ranked #277, highlighting the growth potential and convergence between technology and healthcare
Why OptimizeRx and Ontrak might make you rich.
ROCHESTER, Mich., March 03, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited...
OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down ...
OptimizeRx is disrupting the pharmaceutical sales call with an internet option for marketing drugs to doctors.
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 6.67% and 2.53%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
ROCHESTER, Mich., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results ...
List Celebrates Accomplished Young Talent in Medical Marketing List Celebrates Accomplished Young Talent in Medical Marketing
OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ROCHESTER, Mich., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a...
OptimizeRx and Inari Medical are both crushing the market right now.
ROCHESTER, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been in...
OptimizeRx Corporation (NASDAQ: OPRX) prices its previously announced underwritten public offering of 1.325 million common shares, at $49.50 per share, raising $65.6 million in gross proceeds. Underwrit...
ROCHESTER, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patien...
ROCHESTER, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patien...
As of late, it has definitely been a great time to be an investor in OptimizeRx (OPRX).
ROCHESTER, Mich., Jan. 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported prelimin...
ROCHESTER, Mich., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited...
OptimizeRx did not disappoint on Q3'20 financials, beating on both revenue and EPS. Revenue was up 110% YoY. Strong forward efficiency score of 40% suggests that OptimizeRx is in fine shape based on gro...
ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited...
TelaRep Helps Replace Lost In-Person Interactions Between Life Sciences and Providers TelaRep Helps Replace Lost In-Person Interactions Between Life Sciences and Providers
ROCHESTER, Mich., Dec. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited ...
Komodo's Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving Support for Providers and Patients Komodo's Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving S...
For the First Time, Real-World Data is Used to Deliver Real-Time Care Support Information at the Point-Of-Care For the First Time, Real-World Data is Used to Deliver Real-Time Care Support Information a...
Attributes 217% Revenue Growth to Rapidly Expanding Digital Health Platform Attributes 217% Revenue Growth to Rapidly Expanding Digital Health Platform
Event Brings Providers and Life Sciences Leaders Together to Collaborate on Solutions for Better Patient Outcomes Event Brings Providers and Life Sciences Leaders Together to Collaborate on Solutions fo...
Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation
OptimizeRx Corporation (OPRX) CEO William Febbo on Q3 2020 Results - Earnings Call Transcript
Shares of OptimizeRx (NASDAQ:OPRX) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 240.00% over the past year to $0.07, which beat the ...
ROCHESTER, Mich., Nov. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, reported results for the three and nine mo...
ROCHESTER, Mich., Oct. 26, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a confe...
ROCHESTER, Mich., Oct. 20, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited ...
3Q20 revenue growth of ~100% is an indicator that the company is converting on its pipeline.
ROCHESTER, Mich., Oct. 13, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported prelimin...
NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cla...
OptimizeRx (OPRX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Presented in Collaboration with the Digital Health Coalition and Diligent Health Solutions Presented in Collaboration with the Digital Health Coalition and Diligent Health Solutions
Patients Gain Direct Access to Financial Assistance Relevant to Their Health Journey Prior to Their Medical Appointment
ROCHESTER, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, providers and patients, has been invi...
As of late, it has definitely been a great time to be an investor in OptimizeRx.
Healthcare Consumers Will Gain Access to Financial Assistance and Treatment Support Programs from OptimizeRx at Point-of-Dispense Healthcare Consumers Will Gain Access to Financial Assistance and Treatm...
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2020 Results - Earnings Call Transcript
ROCHESTER, Mich., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported resu...
Change Healthcare Users Gain Access to Prescription Savings and Critical Treatment Information Directly at the Point-of-Care Change Healthcare Users Gain Access to Prescription Savings and Critical Trea...
ROCHESTER, Mich., July 23, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call o...
ROCHESTER, Mich., July 21, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has appointed Greg Wasson, fo...
ROCHESTER, Mich., July 07, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has secured two new SaaS-base...
ROCHESTER, Mich., June 29, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers, providers and patients, has en...
Slowly but surely, the company is cementing its position in the heart of the US healthcare sector, enabling participants to overcome some of the worst effects of its fragmentation.
ROCHESTER, Mich., June 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers, providers, and patients, has f...
About OPRX
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded mess... [Read more...]
| Industry Health Information Services | |
| Stock Exchange NASDAQ | Ticker Symbol OPRX |
Financial Performance
In 2020, OptimizeRx's revenue was $43.31 million, an increase of 76.08% compared to the previous year's $24.60 million. Losses were -$2.21 million, -29.77% less than in 2019.
Analyst Forecasts
According to 4 analysts, the average rating for OptimizeRx stock is "Strong Buy." The 12-month stock price forecast is 72.75, which is an increase of 49.91% from the latest price.